» Articles » PMID: 22870335

DLA Class II Alleles and Haplotypes Are Associated with Risk for and Protection from Chronic Hepatitis in the English Springer Spaniel

Overview
Journal PLoS One
Date 2012 Aug 8
PMID 22870335
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic hepatitis (CH) is common in dogs in the United Kingdom. An increased prevalence of the disease is seen in the English Springer spaniel (ESS), and this breed suffer from a severe form with young to middle aged female dogs being predisposed. The disease shares histological features with those of human viral hepatitis, although the specific aetiological agent has not yet been identified. The aim of the current study was to investigate whether dog leucocyte antigen (DLA) class II alleles and haplotypes are associated with susceptibility/resistance to CH in the ESS. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1 and -DQB1 class II loci were performed in 66 ESSs with CH and 84 healthy controls. There was a significant difference in the distribution of the protective alleles DRB1*00501 (3.0% vs. 12.0%, odds ratio [OR] = 0.23, 95% confidence interval [CI] = 0.06-0.74) and DQB1*00501 (3.8% vs. 12.0%, OR = 0.29, 95% CI = 0.09-0.85) between cases and controls. The haplotype DLA-DRB1*00501/DQA1*00301/DQB1*00501 was present in 11.9% of controls and 3.0% of cases and was significantly associated with protection against disease development (OR = 0.26, 95% CI = 0.08-0.80). There was a significant difference in the distribution of the risk alleles DRB1*00601 (14.4% vs. 6.5%, OR = 2.40, 95% CI = 1.10-5.63) and DQB1*00701 (14.4% vs. 6.5%, OR = 2.40, 95% CI = 1.10-5.63) between cases and controls. A risk haplotype (DLA-DRB1*00601/DQA1*005011/DQB1*00701) was present in 14.4% of cases and 6.5% of controls and conferred an elevated risk of developing CH with an OR of 3.13 (95% CI = 1.20-8.26). These results demonstrate that DLA class II is significantly associated with risk and protection from developing CH in ESSs.

Citing Articles

Whole Genome Sequencing Reveals Multiple Linked Genetic Variants on Canine Chromosome 12 Associated with Risk for Symmetrical Lupoid Onychodystrophy (SLO) in the Bearded Collie.

Gershony L, Belanger J, Hytonen M, Lohi H, Oberbauer A Genes (Basel). 2021; 12(8).

PMID: 34440439 PMC: 8394396. DOI: 10.3390/genes12081265.


Prednisolone therapy for chronic hepatitis in English springer spaniels: a prospective study of 12 cases.

Bayton W, Watson P, Bexfield N Vet Rec. 2020; 186(18):e21.

PMID: 32051291 PMC: 7365563. DOI: 10.1136/vr.105642.


Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs.

Ullal T, Ambrosini Y, Rao S, Webster C, Twedt D J Vet Intern Med. 2019; 33(5):2046-2056.

PMID: 31393054 PMC: 6766481. DOI: 10.1111/jvim.15591.


ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.

Webster C, Center S, Cullen J, Penninck D, Richter K, Twedt D J Vet Intern Med. 2019; 33(3):1173-1200.

PMID: 30844094 PMC: 6524396. DOI: 10.1111/jvim.15467.


DLA class II risk haplotypes for autoimmune diseases in the bearded collie offer insight to autoimmunity signatures across dog breeds.

Gershony L, Belanger J, Short A, Le M, Hytonen M, Lohi H Canine Genet Epidemiol. 2019; 6:2.

PMID: 30783534 PMC: 6376674. DOI: 10.1186/s40575-019-0070-7.


References
1.
Mieli-Vergani G, Vergani D . Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol. 2011; 8(6):320-9. DOI: 10.1038/nrgastro.2011.69. View

2.
Speeti M, Stahls A, Meri S, Westermarck E . Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis. Vet Immunol Immunopathol. 2003; 96(1-2):1-12. DOI: 10.1016/s0165-2427(03)00134-x. View

3.
Clements D, Short A, Barnes A, Kennedy L, Ferguson J, Butterworth S . A candidate gene study of canine joint diseases. J Hered. 2009; 101(1):54-60. DOI: 10.1093/jhered/esp088. View

4.
Bexfield N, Kellam P . Metagenomics and the molecular identification of novel viruses. Vet J. 2010; 190(2):191-198. PMC: 7110547. DOI: 10.1016/j.tvjl.2010.10.014. View

5.
Watson P . Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J. 2004; 167(3):228-41. DOI: 10.1016/S1090-0233(03)00118-7. View